Cargando…

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

BACKGROUND: According to new diagnostic guidelines for Alzheimer’s disease (AD), biomarkers enable estimation of the individual likelihood of underlying AD pathophysiology and the associated risk of progression to AD dementia for patients with mild cognitive impairment (MCI). Nonetheless, how confli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alexopoulos, Panagiotis, Werle, Lukas, Roesler, Jennifer, Thierjung, Nathalie, Gleixner, Lena Sophie, Yakushev, Igor, Laskaris, Nikolaos, Wagenpfeil, Stefan, Gourzis, Philippos, Kurz, Alexander, Perneczky, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146856/ https://www.ncbi.nlm.nih.gov/pubmed/27931251 http://dx.doi.org/10.1186/s13195-016-0220-z

Ejemplares similares

Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
por: Grimmer, Timo, et al.
Publicado: (2012)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
por: Goldhardt, Oliver, et al.
Publicado: (2019)

Frontotemporal Dementia, Manifested as Schizophrenia, with Decreased Heterochromatin on Chromosome 1
por: Gourzis, Philippos, et al.
Publicado: (2012)

Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease
por: Perneczky, R, et al.
Publicado: (2013)

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer’s Disease
por: Li, Rui, et al.
Publicado: (2015)

Pulmonary Embolism Related to Amisulpride Treatment: A Case Report
por: Skokou, Maria, et al.
Publicado: (2013)

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex
por: Mehrabian, Shima, et al.
Publicado: (2015)

Cerebrospinal fluid catecholamines in delirium and dementia
por: Henjum, Kristi, et al.
Publicado: (2021)

Depression in Multiple Sclerosis: A Review of Assessment and Treatment Approaches in Adult and Pediatric Populations
por: Skokou, Maria, et al.
Publicado: (2012)

Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2–17-Year-Old Children and Regional Disparities
por: Kouznetsov, Raissa, et al.
Publicado: (2023)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010)

Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes
por: Trotti, Lynn Marie, et al.
Publicado: (2021)

Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid
por: Boström, Gustaf, et al.
Publicado: (2021)

Dementia treatment versus prevention
por: Perneczky, Robert
Publicado: (2019)

Nicotine consumption during the prodromal phase of schizophrenia – a review of the literature
por: Gogos, Athanasios, et al.
Publicado: (2019)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

Cerebrospinal fluid analysis in individuals with diabetes-related dementia
por: Kanetaka, Hidekazu, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
por: Ljubenkov, Peter A., et al.
Publicado: (2018)

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
por: Foska, Aikaterini, et al.
Publicado: (2022)

Dementia prevention and reserve against neurodegenerative disease
por: Perneczky, Robert
Publicado: (2019)

Physiological Basis of the Couvade Syndrome and Peripartum Onset of Bipolar Disorder in a Man: A Case Report and a Brief Review of the Literature
por: Giourou, Evangelia, et al.
Publicado: (2018)

Hospital workforce mental reaction to the pandemic in a low COVID-19 burden setting: a cross-sectional clinical study
por: Alexopoulos, Panagiotis, et al.
Publicado: (2021)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
por: Bloniecki, Victor, et al.
Publicado: (2014)

VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Depressive symptoms in late life in urban and semi-urban areas of South-West Greece: An undetected disorder?
por: Argyropoulos, Konstantinos, et al.
Publicado: (2015)

Psychological Distress and Health-Related Quality of Life in Public Sector Personnel
por: Malfa, Christina S., et al.
Publicado: (2021)

Low cognitive functioning and depressive symptoms in patients with rheumatoid arthritis and systemic sclerosis: a clinical study
por: Alexopoulos, Panagiotis, et al.
Publicado: (2023)

Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial
por: Messinis, Lambros, et al.
Publicado: (2017)

Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort
por: Niemantsverdriet, Ellis, et al.
Publicado: (2018)

Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer’s Disease in a Naturalistic Clinical Setting
por: Alexopoulos, Panagiotis, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015)

Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
por: van de Beek, M., et al.
Publicado: (2020)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
por: Meeter, Lieke H H, et al.
Publicado: (2019)

Dementia-associated changes of immune cell composition within the cerebrospinal fluid
por: Busse, Stefan, et al.
Publicado: (2021)

The Role of Cerebrospinal Fluid Biomarkers in Dementia and Other Related Neurodegenerative Disorders
por: Paraskevas, George P.
Publicado: (2022)

Case Report: Alzheimer's Dementia Associated With Cerebrospinal Fluid Neurochondrin Autoantibodies
por: Hansen, Niels, et al.
Publicado: (2022)

Genetic Variations Associated with Sleep Disorders in Patients with Schizophrenia: A Systematic Review
por: Assimakopoulos, Konstantinos, et al.
Publicado: (2018)

Prioritizing problems in and solutions to homecare safety of people with dementia: supporting carers, streamlining care
por: Tudor Car, Lorainne, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7qkue4aifcj8kta3hvbmt1jvqd